These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 19843859

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN loss.
    Zhong T, Xu F, Xu J, Liu L, Chen Y.
    Biomed Pharmacother; 2015 Feb; 69():317-25. PubMed ID: 25661377
    [Abstract] [Full Text] [Related]

  • 3. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA, D'Assoro AB, Salisbury JL, Mazzarino MC, Stivala F, Libra M.
    Adv Enzyme Regul; 2006 Feb; 46():249-79. PubMed ID: 16854453
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. PTEN sensitizes epidermal growth factor-mediated proliferation in endometrial carcinoma cells.
    Tang LL, Yokoyama Y, Wan X, Iwagaki S, Niwa K, Tamaya T.
    Oncol Rep; 2006 Apr; 15(4):855-9. PubMed ID: 16525671
    [Abstract] [Full Text] [Related]

  • 6. Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition.
    MacKeigan JP, Taxman DJ, Hunter D, Earp HS, Graves LM, Ting JP.
    Clin Cancer Res; 2002 Jul; 8(7):2091-9. PubMed ID: 12114408
    [Abstract] [Full Text] [Related]

  • 7. Blockade of CCN6 (WISP3) activates growth factor-independent survival and resistance to anoikis in human mammary epithelial cells.
    Huang W, Gonzalez ME, Toy KA, Banerjee M, Kleer CG.
    Cancer Res; 2010 Apr 15; 70(8):3340-50. PubMed ID: 20395207
    [Abstract] [Full Text] [Related]

  • 8. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway.
    Wang DD, Yang SJ, Chen X, Shen HY, Luo LJ, Zhang XH, Zhong SL, Zhao JH, Tang JH.
    Tumour Biol; 2016 Nov 15; 37(11):15315-15324. PubMed ID: 27699665
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
    Festuccia C, Muzi P, Millimaggi D, Biordi L, Gravina GL, Speca S, Angelucci A, Dolo V, Vicentini C, Bologna M.
    Endocr Relat Cancer; 2005 Dec 15; 12(4):983-98. PubMed ID: 16322337
    [Abstract] [Full Text] [Related]

  • 11. Disruption of epithelial architecture caused by loss of PTEN or by oncogenic mutant p110α/PIK3CA but not by HER2 or mutant AKT1.
    Berglund FM, Weerasinghe NR, Davidson L, Lim JC, Eickholt BJ, Leslie NR.
    Oncogene; 2013 Sep 12; 32(37):4417-26. PubMed ID: 23085752
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. PTEN Regulates Renal Extracellular Matrix Deposit via Increased CTGF in Diabetes Mellitus.
    Zhu L, Zhao S, Liu S, Liu Q, Li F, Hao J.
    J Cell Biochem; 2016 May 12; 117(5):1187-98. PubMed ID: 26447680
    [Abstract] [Full Text] [Related]

  • 14. Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase.
    Fu X, Creighton CJ, Biswal NC, Kumar V, Shea M, Herrera S, Contreras A, Gutierrez C, Wang T, Nanda S, Giuliano M, Morrison G, Nardone A, Karlin KL, Westbrook TF, Heiser LM, Anur P, Spellman P, Guichard SM, Smith PD, Davies BR, Klinowska T, Lee AV, Mills GB, Rimawi MF, Hilsenbeck SG, Gray JW, Joshi A, Osborne CK, Schiff R.
    Breast Cancer Res; 2014 Sep 11; 16(5):430. PubMed ID: 25212826
    [Abstract] [Full Text] [Related]

  • 15. PTEN sensitizes MDA-MB-468 cells to inhibition of MEK/Erk signaling for the blockade of cell proliferation.
    Jang K, Kim M, Seo HS, Shin I.
    Oncol Rep; 2010 Sep 11; 24(3):787-93. PubMed ID: 20664988
    [Abstract] [Full Text] [Related]

  • 16. Over expression of PTEN induces apoptosis and prevents cell proliferation in breast cancer cells.
    Wu J, Gao H, Ge W, He J.
    Acta Biochim Pol; 2020 Dec 17; 67(4):515-519. PubMed ID: 33332075
    [Abstract] [Full Text] [Related]

  • 17. Effects of epidermal growth factor receptor and phosphatase and tensin homologue gene expression on the inhibition of U87MG glioblastoma cell proliferation induced by protein kinase inhibitors.
    Xing WJ, Zou Y, Han QL, Dong YC, Deng ZL, Lv XH, Jiang T, Ren H.
    Clin Exp Pharmacol Physiol; 2013 Jan 17; 40(1):13-21. PubMed ID: 23110505
    [Abstract] [Full Text] [Related]

  • 18. PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cells.
    Higgins MJ, Beaver JA, Wong HY, Gustin JP, Lauring JD, Garay JP, Konishi H, Mohseni M, Wang GM, Cidado J, Jelovac D, Cosgrove DP, Tamaki A, Abukhdeir AM, Park BH.
    Cancer Biol Ther; 2011 Feb 01; 11(3):358-67. PubMed ID: 21124076
    [Abstract] [Full Text] [Related]

  • 19. Rac1 protects epithelial cells against anoikis.
    Coniglio SJ, Jou TS, Symons M.
    J Biol Chem; 2001 Jul 27; 276(30):28113-20. PubMed ID: 11369774
    [Abstract] [Full Text] [Related]

  • 20. Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals.
    Zhang D, Bar-Eli M, Meloche S, Brodt P.
    J Biol Chem; 2004 May 07; 279(19):19683-90. PubMed ID: 14993222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.